TL;DR
This study investigated how being born very preterm with very low birth weight (VLBW) impacts DNA methylation patterns in adulthood, comparing VLBW individuals to their siblings. While blood showed no significant differences, adipose tissue revealed substantial, tissue-specific epigenetic changes linked to lipid metabolism and neurodevelopment, suggesting long-term health implications.
What Problem Does This Paper Address?
The "Developmental Origins of Health and Disease" (DOHaD) hypothesis posits that early life exposures can permanently alter organ structure and function, leading to long-term health issues. Epigenetic modifications, particularly DNA methylation (DNAm), are a key proposed mechanism for these lasting changes. While previous studies have linked preterm birth and low birth weight to increased cardiometabolic risks, the specific epigenetic alterations and their persistence into adulthood, especially in relevant tissues like adipose tissue, remain less understood. This paper aims to address this gap by examining tissue-specific DNAm differences in adults born VLBW compared to their genetically similar siblings, thereby controlling for familial environmental and genetic confounders.
Methods
The researchers employed an epigenome-wide association study (EWAS) approach using the Illumina EPIC 850K BeadChip array to assess DNAm at over 850,000 CpG sites. This was performed on both blood and abdominal subcutaneous adipose tissue samples from participants. Statistical analyses included mixed-effects models and paired t-tests, adjusted for potential confounders such as age, sex, batch effects, estimated cell composition in blood, maternal smoking, BMI, and participant smoking. False discovery rate (FDR) correction was applied to account for multiple testing. Ingenuity Pathway Analysis (IPA) was used to identify biological pathways enriched by the differentially methylated sites.
Datasets
The study utilized data from the "Adults Born Preterm Sibling Study," which included 75 adults born preterm with very low birth weight (VLBW; <1500 g) and 73 same-sex sibling controls. Participants were recruited from the Finnish Medical Birth Register, the Helsinki Study of Very Low Birth Weight Adults (HeSVA), and the Preterm Birth, Pregnancy and Offspring Health in Adult Life (ESTER) study. DNAm data was collected from blood and adipose tissue samples.
Key Insights and Ideas
- Tissue Specificity is Crucial: The most striking finding is the stark contrast between blood and adipose tissue. While blood DNAm showed no significant differences, adipose tissue revealed substantial epigenetic alterations. This highlights the importance of studying relevant target tissues rather than relying solely on easily accessible blood samples for understanding the long-term consequences of early life exposures.
- Adipose Tissue as a "Memory" of Early Life: The significant DNAm changes in adipose tissue suggest that this tissue may retain a "memory" of early life conditions, potentially mediating the increased risk of metabolic and cardiovascular diseases observed in VLBW individuals.
- Lipid Metabolism and Neurodevelopment Pathways Affected: The differentially methylated sites in adipose tissue were enriched in pathways related to lipid metabolism, neurodevelopment, and cardiometabolic regulation. This provides a molecular basis for the known health challenges faced by individuals born preterm.
- Sibling Design Strengthens Findings: Using sibling controls is a powerful design choice. It helps to minimize confounding from shared genetics and family environment, making the observed differences more likely attributable to the VLBW exposure itself.
Key Results
- Blood DNAm: No significant differences in DNA methylation were found in blood samples between VLBW adults and their siblings after adjusting for multiple testing.
- Adipose Tissue DNAm: In adipose tissue, 458 CpG sites were differentially methylated (FDR p < 0.05) between VLBW adults and their siblings. Of these, 432 (94%) were hypermethylated in the VLBW group.
- Top Genes: Key genes associated with differential methylation in adipose tissue included FADS2 (lipid metabolism) and KIF26A (neural development).
- Pathway Enrichment: IPA identified 81 biological pathways significantly enriched by the differentially methylated sites in adipose tissue, with a majority showing possible downregulation. These pathways were related to lipid metabolism, neurodevelopment, and cardiometabolic regulation.
- Replication: Seven previously discovered CpG sites in blood, linked to genes like EBF4, HIF3A, and GLI2, were replicated in the current study's blood samples, though with some variations in methylation direction.
Limitations and Future Work
The authors acknowledge several limitations. The study size, while robust for a sibling comparison, is still limited, potentially impacting statistical power. The blood EWAS showed a tendency towards deflation, possibly due to the sample size. The generalizability of the findings may be limited as participants were volunteers for an extensive assessment. IPA's assumption that hypermethylation reflects gene downregulation is a simplification that requires cautious interpretation. Furthermore, the study could not account for DNA sequence polymorphisms, which can influence DNAm.
Future work could focus on longitudinal studies to track DNAm changes over time, investigate the functional consequences of these epigenetic alterations in more detail, and explore the potential for targeted interventions, possibly through dietary modifications, to mitigate the long-term health risks associated with VLBW. Further research into the specific mechanisms by which adipose tissue DNAm influences cardiometabolic health and neurodevelopment is also warranted.
Summary updated